Belgium is one of the largest producers of MDMA (ecstasy) in the world. The illegal production and sale of ecstasy is a source of income for organised crime and has a negative impact on public health, the environment and society.

In 2023, Belgium took a significant step in the discussion on drug policy by organising the XTC Expo. This exhibition allowed visitors to discover what a legal, regulated ecstasy market might look like. Through three fictional spaces—smartshop, pharmacy and nightclub—the expo invited people to imagine and experience alternative futures.

The XTC Expo was the first of its kind. With over 1,200 visitors and 900 survey responses, it revealed strong public support for a legally regulated market with strict controls. This final report presents the concept, the fictional spaces, the responses of visitors and the lessons learned.

XTC Expo – Final report

CND Chair's Special Event to commemorate the International Day against Drug Abuse and Illicit Trafficking and to launch the 2025 UNODC World Drug Report

 presents the latest global, regional, and subregional data and trends in drug demand and supply, with an emphasis on usability and accessibility through an interactive online format. The World Drug Report 2025 will provide a wealth of data and analysis on the latest trends in drug demand and supply and cross-cutting issues together with three thematic chapters on: the impact of drug use with a focus on health; the links between drug trafficking and organized crime; and the impact of drugs on the environment in Europe. The report will be structured around four modules: (i) the three thematic chapters will be presented in the Thematic Contemporary Issues booklet; (ii) the web-based Drug Market Patterns and Trends module will contain the latest analysis of global, regional and subregional estimates of and trends in drug demand and health consequences, supply, and drug-related criminal justice system offering graphs, infographics, maps, and key summary messages in an interactive and searchable way; (iii) the booklet on Key Findings will summarize the analysis presented in the Drug market patterns and trends module and the three thematic chapters; while (iv) the Special Points of Interest booklet offers a framework for the main takeaways and policy implications that can be drawn from those findings.

, the Chair of the 68th session of the CND will hold an event to mark the World Drug Day and to launch the 2025 World Drug Report.

CND Chair's special event: World Drug Day - Launch of the 2025 UNODC World Drug Report

In 2025, the Commission on Narcotic Drugs (CND) will continue its annual thematic discussions as part of a multi-year workplan (2024–2028) to assess and implement international drug policy commitments. These discussions aim to address key challenges identified in the 2019 Ministerial Declaration and prepare the ground for a comprehensive stock-taking in 2028.

The 2025 discussions will focus on urgent global issues, with dedicated sessions for cross-cutting topics and “Other substantive matters” that Member States wish to raise. 

Each session will begin with a presentation by UNODC’s Research and Analysis Branch and feature a moderated panel of experts from Member States, international and regional organisations, UN entities, and civil society. Interactive discussions will follow, allowing for broad participation and the sharing of national experiences and concerns.

Thematic discussions on challenges identified in the 2019 Ministerial Declaration

Drug treatment and health services continue to fall short of meeting needs, and drug-related deaths have increased.

Rates of HIV, hepatitis C, and other blood-borne diseases associated with drug use (including injecting drug use) remain high in some countries.

The adverse health consequences and risks associated with new psychoactive substances have reached alarming levels.

The availability of internationally controlled substances for medical and scientific purposes, including for pain relief and palliative care, remains low to non-existent in many parts of the world.

CND Intersessional meeting - Thematic discussions on the implementation of all international drug policy commitments following up to the 2019 Ministerial Declaration (Autumn 2025)

In 2025, the European Union will adopt a new EU Drug Strategy that will define the political direction and priorities for the period 2026–2030.

While the current strategy (2021–2025) recognises the pillars of drug supply reduction, demand reduction, and harm reduction, its implementation has remained disproportionately focused on law enforcement and punitive measures.

This imbalance has not led to improved public safety—instead, it has worsened health outcomes, increased stigma, and deepened the marginalisation of people who use drugs.

Access to essential health and harm reduction services continues to be limited, particularly for vulnerable and underserved communities.

As the next EU Drug Strategy is being shaped, we face a critical opportunity to advocate for a more balanced, health-centred, and human rights-based approach to drug policy.

To seize this momentum, leading European drug policy networks — including C-EHRN, EHRA, IDPC, and HFHR — have launched the European Drug Policy Campaign.

This initiative is supported by the European Drug Policy Alliance, a coalition of civil society and harm reduction experts working to influence the content and implementation of the new strategy.

The campaign will be presented during a webinar on 26 June, the Support, Don't Punish Global Day of Action, bringing together policymakers, civil society representatives, and European drug policy experts to foster dialogue and build momentum for drug policy reform in the EU.

This webinar will feature diverse perspectives from key stakeholders and serve as a platform to mobilise support for a more just, inclusive, and effective EU Drug Strategy.

Harm reduction works! A call to invest in a european health-based drug policy - Campaign webinar

Delivered at the 5th Brandenburg Forum in Geneva : “Expanding the Conversation on the Human Rights Implications of Drug Policy”

Excellencies,
Distinguished participants,
Colleagues,

It can stigmatize and isolate people, or it can help heal connections with others.

More and more, we see that it’s human connection and evidence-based approaches – not punishment – that transform and uplift the lives of people affected by drug use disorders.

Those same policies reinforce social bonds and create healthier, more resilient communities and societies.

I welcome the growing acknowledgement by States that discussions on drug policy must take into account States’ human rights obligations.

This forum is an important part of our efforts to exchange views and best practices, and demonstrate how human rights offer us a path towards a more humane and effective approach to drugs.

Distinguished participants, dear friends,

That new path is desperately needed, because the so-called war on drugs has failed. It has neither reduced drug use, nor the illicit drug trade, nor the production and consumption of a growing range and quantity of illicit substances.

Some 292 million people around the world used narcotic drugs in 2022 – the latest year for which we have figures. That represents a 20 per cent increase over a decade.

New, increasingly potent drugs are emerging in several high-income countries, resulting in an increase in overdose deaths.

Not only has the war on drugs failed; the militarization of drug control continues to lead to many unnecessary deaths, and to the excessive and disproportionate imprisonment of certain groups, including vulnerable people.

Some of those deaths are state-sponsored killings. Thirty-four countries still retain the death penalty for drug offenses, killing hundreds of people every year. More than 40 percent of state executions in 2023 were for offences related to drug offences. This proportion has also risen sharply over the past two years.

Punitive and militarized drug policies are also linked with corruption and illicit financial flows. The profits from drug trafficking may be used to finance violence, terrorism, and armed conflict.

Economies based on illicit drugs are also having a large and growing impact on our climate and environment, from water stress to deforestation and the dumping of toxic waste.

This forum’s focus on the negative impact of drug policy on economic, social and cultural rights is a very important one.

It is increasingly clear and documented that the war on drugs is harming public health, and people who use drugs are not getting the help they need. Though an estimated 64 million people worldwide suffer from drug use disorders, only one in 11 is in treatment.

Women are particularly affected. Only one in 18 women with drug use disorders is in treatment, compared to one in seven men.

Fear of arrest and widespread stigma have deterred people from seeking drug treatment, healthcare and support, including medical care for HIV/AIDS.

Homelessness is both a cause and consequence of drug use, and contributes to poor health among people who use drugs. Programmes such as Housing First that prioritise stable housing as the basis for recovery have proven their value in a number of countries. I encourage States to share their experiences and explore how such initiatives can be established and expanded.

Poorly designed drug policy also harms other human rights. In some countries, evidence of drug use or a criminal record for drug-related crimes can disqualify people from social benefits or restrict access to education or employment.

Blunt, punitive approaches have disproportionately affected some of the most marginalized communities, and perpetuated cycles of exclusion.

For example, States often overpolice Indigenous Peoples who cultivate drug crops to make a living.

The illicit drug economy also undermines the rights of people who are vulnerable to exploitation, including farmers, women, minorities, people of African descent and Indigenous Peoples. As States make efforts to curb the illicit drug trade, they must invest in viable and sustainable economic alternatives, in consultation with those affected. I welcome the recent resolution on alternative development by the Commission on Narcotic Drugs which supports this approach.

Excellencies,
Distinguished participants,

Looking forward, we must continue pursuing humane drug policies that advance all human rights, including economic, social and cultural rights.

This requires concerted action by all – primarily by States, but also civil society, and the United Nations system, among many others.

First, I encourage all States to integrate the International Guidelines on Human Rights and Drug Policy into their national laws and policies, including with regard to housing, employment, harm reduction and protecting marginalised communities.

I welcome the decision by the UN Committee on Economic, Social and Cultural Rights to prepare a new General Comment on States’ legal obligations around drug policy. This should provide important additional guidance.

Second, harm reduction measures, such as needle exchange programmes, safe consumption sites, and access to information and healthcare, are crucial. States need to tackle shame and stigma around treatment for drug use disorders, and remove legal and policy barriers to access these services. We must show that they save and improve lives, for people, communities and societies at large.

Third, decriminalising drug use – accompanied by harm reduction measures and support for social reintegration - is another key element. Criminalizing people with a drug use disorder deters them from seeking treatment and creates further stigma and isolation.

Fourth, there is an urgent need to abolish the death penalty for drug-related offences. Executing people for these offences does not comply with international human rights law, which specifies that the death penalty can only be imposed for the most serious crimes involving intentional killing. The United Nations, as a matter of policy, opposes the death penalty in all circumstances.

Fifth, responsible regulation should aim to take control of illegal drug markets, eliminate profits from illegal trafficking, criminality and violence, and protect the environment.

Sixth, it is essential to include those most affected by drug use disorders in all decisions, policies and laws. The Scottish Charter of Rights for People Affected by Substance Abuse is an example of a policy developed through a multistakeholder process, reflecting the unique needs of different groups, including people who use drugs. I hope it can serve as inspiration to other countries around the world.

My Office and I personally will continue to do everything in our power to ensure coherence across the United Nations system on this issue, which affects hundreds of millions of people around the world.

Together, with your support, we must - and will - keep human rights at the centre of global drug policy, as we work for dignity, justice and equality for all.

'We must continue pursuing humane drug policies that advance all human rights' - UN Human Rights Chief

Full-day event (exact schedule to be confirmed)


 Free for all NNEF members (Not a member yet? No problem! Membership is free)

This event is all about open discussion, learning, and collaboration, bringing together people passionate about harm reduction and improving services. Whether you’ve been involved for years or are new to the field, this is your chance to hear from expert speakers, share experiences, and shape the future of needle exchange services in the UK.

Speaker information coming soon! Stay tuned for updates on our fantastic lineup of speakers and sessions.

We can’t wait to see you there—register now to secure your place!

National Needle Exchange Forum (NNEF)

In 2025, the European Union will adopt a new EU Drug Strategy that will define priorities for 2026–2030. As this critical moment approaches, we call for a shift towards a balanced, health-focused, and human rights-based approach to drug policy.

To support this effort, we are launching the 

, coordinated by C-EHRN in collaboration with the 

Eurasian Harm Reduction Association (EHRA)

International Drug Policy Consortium (IDPC)

Helsinki Foundation for Human Rights (HFHR)

. The campaign is accompanied by the publication of a new 

Support Don’t Punish Global Day of Action

 outlines urgent recommendations for the EU and Member States, including:

Ensuring a balanced EU Drug Strategy 2026–2030

Establishing dedicated EU-level funding for harm reduction

Prioritising decriminalisation and responsible regulation

We will present the campaign’s goals and share ways civil society organisations and allies can get involved.

Harm reduction works! A call to invest in a European health-based drug policy

In 2019, Andrea Siclari was diagnosed with stage 4 colon cancer. Alongside medical treatments, he participated in a LSD-assisted therapy in Switzerland within a clinical trial programme to address his deep anxiety. Andrea’s experience showcases a scenario in which a patient suffering from one of the most commonly known terminal illnesses was able to greatly improve his outlook and quality of life through psychedelic-assisted therapy. LSD has shown great results as a potential treatment for common conditions such as anxiety, depression, PTSD, addiction, and existential distress at the end-of-life. But access remains out of reach for most Europeans. 

 to foster equitable, timely, affordable, safe, and legal access to innovative psychedelic-assisted therapies.

How LSD saved my mind - Andrea's healing story

Harm reduction has long been a cornerstone of European public health, minimising drug use risks like overdose deaths or preventing the spread of infectious diseases. These interventions have been instrumental in improving the health and wellbeing of people who use drugs (PWUD).

However, in the last few years, the financial sustainability of many harm reduction initiatives has been under serious threat. A growing funding crisis, driven by shifting political priorities and a 

 to drug policy within the European Union (EU), is threatening to dismantle decades of progress. 

This shifting landscape in harm reduction funding has hit at a critical time. Europe is facing an increasingly complex drug landscape, with hundreds of novel psychoactive substances (NPS) and synthetic opioids 

Speaking to TalkingDrugs, Alexei Lakhov, Executive Director of the 

European Network for People Who Use Drugs (EuroNPUD)

 highlighted that “this complexity often increases the demand for specialised harm reduction services”, further straining service providers.

European harm reduction has historically been financed through national health funds, international aid and EU-wide grants. Yet, a 

 from Harm Reduction International (HRI) into harm reduction funding has underscored how national and international donors have scaled back many of their financial commitments to harm reduction. European countries, particularly those classified as high or upper-middle income, are 

 for key international funding sources such as the Global Fund to Fight AIDS. While understandable, this shift has left critical harm reduction programmes struggling with severe budget shortfalls.

Political shifts toward right-leaning governments across Europe have further amplified this crisis, as policymakers shift their focus to drug-related security concerns and supply side interventions over harm reduction. While the 

 continues to support harm reduction, national concerns around drug-related insecurity have prioritised law enforcement-based approaches, leaving many harm reduction services with reduced resources.

pioneer of European harm reduction since the 1970s

, is one of the many countries facing funding cuts that threaten its services’ stability. For over 35 years, 

 has played a key role in conducting research on harm reduction and providing updated information on drug trends and alerts to PWUD across the Netherlands through their 

. Now, however, they are facing serious cuts.

European harm reduction is facing a funding crisis

Legal amendments that make cannabis smokers 

 if a neighbour reports them and claims they can smell the drug, have infuriated two NGOs.

"The new cannabis amendments demonstrate a government that has lost all sense of direction and is now a hostage to the cannabinoid industry," ReLeaf Malta and Moviment Graffitti said in a statement on Sunday.

"The violation of privacy and anonymity reduces personal rights and gives fresh impetus to a culture of stigma against thousands of cannabis consumers and cultivators in Malta and Gozo," they added.

The new, stricter regulations against people who smoke and cultivate cannabis were approved by parliament earlier this month.

Malta: NGOs infuriated by new regulations on cannabis smoke that annoys neighbours

A French law is set to unleash invasive new police surveillance powers.

 Fuelled by absurd rhetoric, the government is proposing what has been dubbed “the worst surveillance law in the EU”. Experts warn that it will fail to achieve its aims. However, the broad scope of the law means the powers can be used against migrants, their supporters, and to crack down on dissent. As official reports have made clear, dealing with drug use and trafficking requires long-term, low-tech policies – not high-tech police surveillance powers.

The French government is stepping up its war on drugs, combining absurd rhetoric (with smoking a joint compared to shooting a child in the head) and new legislation.

This repressive approach is similar to that favoured in many other countries around the world, where it has also failed to reduce drug trafficking or use.

The French government’s proposal includes some particularly invasive surveillance measures, including:

remote activation of phones by the police; and

mass surveillance of internet and telecoms traffic.

The broad scope of the law means these powers can also be used against irregular migrants, those providing them with aid or support, and political dissidents.

There may soon be similar measures proposed at European level, as part of the EU’s new internal security strategy.

In 2014, the French government warned that the country was at a “tipping point” and called for the fight against drug trafficking to become “a national cause”. The government’s latest plan to address the problem has two components. First, try to shock the public. Second, pass new legislation on ‘narcotraffic’.

This attempt to shock people has led to a stream of ridiculous statements from officials. If there is a competition amongst them, then Bruno Retailleau, the interior minister, is the clear winner. He has warned that smoking a joint is akin to “two bullets in the head of a five-year-old kid; this is a youth who has been stabbed 50 times with a knife and burned alive.”

Over the years, there has been an undeniable rise in violence. A book published last year looked at the phenomenon of young “shooters” – children and young adults who become involved in gun violence. The authors argued that young shooters were similar to 

, Mexico’s notorious killers for hire. The parallel between France and the world’s most violent country for drug trafficking quickly spread. Retailleau, the interior minister (yes, him again), claimed there had been a “Mexicanisation” of France.

The comparison is absurd. Mexico holds the record for disappearances and deaths related to the war on drugs. Amnesty International, citing Mexican government data, says that some 30 people disappear every day in the country. This equates to more than one person every hour, and a total of almost 11,000 people annually. In France, there were 110 deaths linked to drug trafficking in 2024, according to interior ministry data.

France is just one of many countries taking an ever-more repressive approach to drugs. 

, a global network of over 190 NGOs that promotes person-centred, rights-affirming drug policies at the national, regional and international levels, told 

“The reality that we see across the globe is that repressive measures have comprehensively failed to suppress the drug trade and have instead led to the drastic erosion of fundamental rights. This move in France is unfortunately no exception.”

These quick fixes get their proponents headlines in the press, but they provide few positive long-term results. The French Court of Auditors recently warned that the entire system of youth assistance is screaming for survival. It requires long-term human and financial investment. Instead, resources are directed elsewhere.

A government report on limiting children’s involvement in drug trafficking proposed a number of potential solutions to the problem. They include proposals for better follow-up from local services in providing care, and improved social services for the youth and their families. They do not include proposals to give the police military-grade surveillance powers. That, however, is precisely what is happening.

France: How the “war on drugs” is turbo-charging surveillance powers

The Netherlands expanded a government-run initiative on Monday allowing legal cannabis sales.

While growing cannabis is still illegal, cannabis shops — known as coffeeshops — in 10 municipalities will be allowed to sell marijuana from 10 licensed producers.

“Weed was sold here legally for 50 years, but the production was never legal. So it’s finally time to end that crazy, unexplainable situation and make it a legal professional sector,” Rick Bakker, commercial director at Hollandse Hoogtes, one of the regulated producers, told The Associated Press.

Some 80 coffeeshops are taking part in the experiment which advocates hope this will ultimately end a long-standing legal anomaly — you can buy and sell small amounts of weed without fear of prosecution in the Netherlands, but growing it commercially remains illegal.

Bakker's company in Bemmel, near the German border, is indistinguishable from the surrounding greenhouses producing tomatoes and peppers. But it makes 200 kilograms (440 pounds) of weed per week and is one of the largest producers in the experiment.

A trailblazer in decriminalizing pot since the 1970s, the Netherlands has grown more conservative. 

, long a magnet for marijuana smokers, has been closing coffeeshops in recent years and has banned smoking weed on some of the cobbled streets that make up its historic center.

Advocates have been pushing for a legal growing for years, citing the safety of the product as well as concerns about crime.

Western Europe